Incando Therapeutics Revenue

Medical Equipment Manufacturing • United States • 1-10 Employees

Incando Therapeutics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at Incando Therapeutics

Cheng-Wei Pei

Co-Founder And Cto

Company overview

Headquarters	United States
Websites	incando.net incandotherapeutics.com
NAICS	3391
Employees	1-10
Socials

Incando Therapeutics Email Formats

Incando Therapeutics uses 1 email format. The most common is {first name} (e.g., john@incando.net), used 100% of the time.

Format	Example	Percentage
{first name}	john@incando.net	100%

About Incando Therapeutics

Founded in 2019, Incando Therapeutics is a medical technology firm developing light-based therapies for intractable, hard to treat cancers. Incando is currently targeting brain cancer (Glioblastoma) with a view towards applying our solutions to other variants of the disease. Recognising the established MedTech ecosystem in Singapore and how the nation has, in recent years, become a hotbed for the MedTech sector, the firm seeks to develop novel and safer solutions for cancer therapy, complementing current methods that are already in use. Incando Therapeutics’ proprietary technology utilises wireless powering – jointly developed at Stanford University and the National University of Singapore (NUS) – to drive phototherapy for the long-term treatment of cancers. This is done with implantable light devices that can be controlled via wireless technology to dispense on-demand treatments directly to tumours. This approach is much safer than current treatments and brings forth an important new tool in the battle against complex and long-term cancers. The firm has partnered with top neurosurgeons at the National University Hospital in Singapore to refine the implants and develop treatment procedures towards clinical testing. The firm successfully raised its seed round in 2020, and has a presence in Singapore, Hong Kong, and the US.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Employees by Department

Incando Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Incando Therapeutics has never raised funding before.

Incando Therapeutics Tech Stack

Discover the technologies and tools that power Incando Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Twitter Emoji

Font scripts

Gravatar

Miscellaneous

WordPress.com

PaaS

Nginx

Reverse proxies

HTTP/3

Miscellaneous

PHP

Programming languages

Open Graph

Miscellaneous

HSTS

Security

WordPress

Blogs

Swiper

JavaScript libraries

MySQL

Databases

Frequently asked questions

Incando Therapeutics is located in US.

Incando Therapeutics generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Incando Therapeutics has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Incando Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Incando Therapeutics

Cheng-Wei Pei

Co-Founder And Cto

4.8

40,000 users